TSCAN THERAPEUTICS, INC. Shareholders' Equity
TSCAN THERAPEUTICS, INC. (TCRX) had Shareholders' Equity of $69.02 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $69.02M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $96.92M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $123.12M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $144.02M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $69.02M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $96.92M 10-Q · filed 2026-08-12 |
| 2025-12-31 | $123.12M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $144.02M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $176.71M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $210.20M 10-Q · filed 2026-08-12 |
| 2024-12-31 | $240.97M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $229.09M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $255.22M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $122.97M 10-Q · filed 2025-08-12 |
| 2023-12-31 | $150.87M 10-K · filed 2026-03-04 |
| 2023-09-30 | $168.96M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $190.61M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $78.02M 10-Q · filed 2024-08-12 |
| 2022-12-31 | $99.43M 10-K · filed 2025-03-05 |
| 2022-09-30 | $116.66M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $131.65M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $145.69M 10-Q · filed 2023-08-10 |
| 2021-12-31 | $160.78M 10-K · filed 2024-03-06 |
| 2021-09-30 | $174.07M 10-Q · filed 2022-11-09 |
| 2021-06-30 | -$60.03M 10-Q · filed 2022-11-09 |
| 2021-03-31 | -$49.92M 10-Q · filed 2022-08-10 |
| 2020-12-31 | -$42.46M 10-K · filed 2023-03-08 |
| 2020-09-30 | -$34.84M 10-Q · filed 2021-11-10 |
| 2020-06-30 | -$27.80M 10-Q · filed 2021-11-10 |
| 2020-03-31 | -$22.34M 10-Q · filed 2021-08-19 |
| 2019-12-31 | -$17.14M 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |